Search Results (487)

Background/Objectives: Improper medication use, premature treatment discontinuation, and inadequate disposal contribute to irrational drug consumption and environmental contamination. Although pharmaceutical take-back programs have expanded globally, real-world evidence on household medication accumulation in academic and community settings remains limited. This study aimed to describe longitudinal patterns of medication collection during an eleven-year university-based take-back campaign, with detailed pharmacological characterization available for selected post-pandemic years. Methods: Real-world data were analyzed from a sustainable medication take-back campaign conducted annually at the University of Colima between 2015 and 2025. Expired or unused medications were voluntarily returned by students and community members. Total collected weight was recorded for all years, while detailed classification by dosage form, Anatomical Therapeutic Chemical (ATC) group, and Mexican regulatory fraction (Fractions II, IV, V, and VI) was performed for years with complete records (2023–2025). All materials were disposed of through an authorized hazardous-waste company in compliance with NOM-052-SEMARNAT-2005. Descriptive analyses were performed using SPSS version 29.0. Results: Approximately 3.9 tons of pharmaceutical products were collected over eleven years, reflecting persistent household accumulation of unused or expired medicines. In the years with detailed analysis, oral solid dosage forms predominated. In 2025, ATC groups M, A, and C were most frequently returned, consistent with medications used for chronic conditions. Therapeutic composition varied annually, with NSAIDs/analgesics predominating in 2023–2024 and antibiotics in 2025. Across analyzed years, 5–7% of collected items corresponded to non-medication products. Conclusions: This long-term campaign provides valuable real-world evidence on medication non-use and disposal, highlighting ongoing challenges in rational medicine use, treatment continuity, and environmentally responsible pharmaceutical waste management. Full article

Background/Objectives: Transmission Raman spectroscopy (TRS) is widely used for non-destructive quantification of solid dosage forms, yet most applications involve high-dose formulations (>5% w/w active pharmaceutical ingredient (API)). This study addresses the underexplored area of low-dose drug analysis by developing a TRS method for dimdazenil capsules containing only ~1.5% w/w API—a concentration rarely reported in the current TRS literature. Methods: A partial least squares (PLS) model was built using TRS spectra of dimdazenil capsules, with sample variability introduced via a design of experiments (DoE) approach. Model performance was validated against reference high-performance liquid chromatography (HPLC) data from independent samples and three commercial batches, incorporating specificity checks and greenness assessment via AGREEprep. Results: The TRS method achieved reliable variation assessment with acceptable accuracy, showing relative errors below 5.0% across all validation sets despite a minor systematic bias of ~−2.87%. Analysis required no sample preparation and took less than 150 s per capsule. Specificity was ensured by the unique 1628 cm⁻¹ band of dimdazenil, with no interference from excipients confirmed by spectral examination and multivariate statistical methods. The method scored 0.86 on AGREEprep, highlighting its environmental superiority over HPLC. Conclusions: This work demonstrates that TRS can be reliably extended to low-dose solid dosage forms (~1.5% w/w), a concentration range rarely addressed in the existing TRS literature. This significantly broadens its applicability in pharmaceutical quality control and supports its potential integration into continuous manufacturing for challenging low-concentration products. Full article

In order to prepare alkyl-functionalized reduced graphene oxide more simply, economically and environmentally, we adopt a two-step method of first reduction and then surface grafting. Graphite oxide (GtO) is first exfoliated to thermally-reduced graphene oxide (TRGO) and then, in a heat-induced solid-state reaction, converted to lauryl-functionalized TRGO (LTRGO). During the second step, lauryl radicals generated from the decomposition of lauroyl peroxide (LPO) open the epoxide rings on TRGO, covalently grafting the alkyl chains. The average water contact angle of LTRGO is 135.5°, and it disperses stably in base oil without surfactants or other additives. Four-ball test results show when the dosage of LTRGO is 75 mg/L, the average friction coefficient and wear scar diameter of the Formosa Plastics base oil (100 N) are decreased by 20.8% and 15.4%, respectively. The morphology and element analysis after ball-on-disk friction tests showed that the stable LTRGO physical friction adsorption film and metal oxide friction chemical reaction film could be formed between the friction pairs, thus reducing the friction wear. Full article

Background: While probiotics may offer therapeutic benefits for alcoholic liver disease (ALD), their impact on inflammatory markers in ALD patients is still uncertain. Objective: This study aims to investigate the effects of probiotic supplementation on inflammatory biomarkers in patients with alcoholic liver disease, particularly examining its role in modulating interleukin-6 (IL-6) levels. Methods: A comprehensive search was performed across PubMed, Embase, and Web of Science to identify randomized controlled trials investigating probiotic interventions in patients with alcoholic liver disease. Seven independent comparisons were chosen for meta-analysis to evaluate probiotics’ effects on inflammatory markers, with subgroup analyses examining the impact of region, formulation type, and gender. Results: The findings demonstrated that probiotics led to a significant reduction in IL-6 levels (SMD = −0.68, 95% CI [−1.15; −0.20], p = 0.005). No statistically significant effect of probiotics on interleukin-1β (IL-1β) (SMD = −0.35, 95% CI [−0.87, 0.17], p = 0.18) or tumor necrosis factor alpha (TNF-α) levels (SMD = −0.73, 95% CI [−1.68, 0.21], p = 0.13) was observed. Notably, probiotics were associated with a significant increase in interleukin-10 (IL-10) levels (SMD = 0.93,95% CI [−0.02; 1.87], p = 0.05). Subgroup analyses further revealed that the efficacy of probiotics in reducing IL-6 levels was more pronounced in studies characterized by higher proportions of Asian participants, solid dosage forms, and male subjects. Conclusions: Probiotics have notably reduced IL-6 levels by altering the gut microbiota and increased IL-10 levels, with limited impact on IL-1β and TNF-α. These results suggest probiotics could be used to treat ALD and emphasize the need for personalized probiotic approaches for different populations. Full article

Powder melt extrusion (PME) represents an alternative approach for personalized oral dosage forms. Furthermore, the utilization of agricultural waste has gained increasing attention because it helps reduce pollution from waste. This study investigated cellulose powders and short fibers from agricultural waste as supporting materials for the PME-based production of shape-changing levodopa printlets. Formulations containing cellulose powder (CP), cassava short fiber (CSF), and pineapple short fiber (PSF) demonstrated successful printing. The selected formulations were characterized for morphology, thermal transitions, crystallinity, shape-changing behavior, and drug release. CSF demonstrated superior printability, enhanced shape recovery, and the greatest reduction in crystallinity, supporting amorphous solid dispersion formation. Levodopa-loaded printlets showed uniform and high drug content. The formulation containing 5% CSF and levodopa exhibited the fastest initial release, attributed to its low crystallinity and Super Case II transport mechanism. Overall, this study highlights the feasibility of using natural cellulose as an additive in PME to develop sustainable, shape-changing drug delivery systems and advances PME knowledge by integrating agricultural waste derived cellulose fibers with levodopa processing that provide new insight into the material–process–performance relationship in PME systems. Full article

Background/Objectives: Canagliflozin (CFZ) is the first sodium glucose co-transporter 2 (SGLT-2) inhibitor and is characterized by poor water solubility and permeability, resulting in low oral bioavailability. In this study, a CFZ nanosuspension (CFZ-NS) was converted into a solid form to improve the physical stability of CFZ nanocrystals (CFZ-NCs) and to enable formulation as a tablet dosage form. Methods: To achieve adequate redispersibility of dried CFZ-NCs, fluid bed granulation and spray-drying methods were employed, and the effects of critical process parameters were investigated. The stability of spray-dried nanocrystal tablets (NCs-SD-TAB) was evaluated over a three-month period under storage conditions of 25 ± 2 °C with 60 ± 5% relative humidity (RH) and 40 ± 2 °C with 75 ± 5% RH. Results: The highest redispersibility index (94%) was obtained using the spray-drying method. Tablets prepared with spray-dried NCs-SD-TAB exhibited a significantly higher in vitro dissolution rate under non-sink conditions compared with control tablets prepared using unprocessed CFZ with the same excipients, as well as the marketed product. NCs-SD-TAB showed an approximately three-fold increase in drug release at 15 min in 0.1 N HCl, with a pH 4.5 acetate buffer and pH 6.8 phosphate buffer, which simulate gastrointestinal pH conditions, relative to the marketed product. Conclusions: Overall, these results indicate that nanocrystal technology represents a promising approach for CFZ as an improved oral drug-delivery system, primarily due to its solubility enhancement capabilities. Full article

Background: Therapeutic drug monitoring (TDM) is essential for ensuring safe, effective, and individualized anti-infective therapy, particularly in patients with complex clinical needs. Variability in pharmacokinetics, challenges in drug administration, and high-dose regimens can compromise adherence and increase the risk of therapeutic failure or resistance. Swallowing difficulties, a common barrier to oral therapy, often necessitate alternative administration routes or customized formulations. However, interventions such as pharmaceutical compounding or manipulation of solid dosage forms may significantly alter drug bioavailability and pharmacokinetic profiles, making TDM indispensable for guiding dose adjustments and maintaining therapeutic targets. Objectives: This review not only emphasizes the clinical relevance of TDM but also addresses practical strategies that enable therapy when standard formulations are unsuitable or unavailable, while minimizing risks that could compromise treatment efficacy and safety. Special focus is given to anti-infective agents, such as antibiotics, antivirals, and antifungals, illustrating how TDM, combined with tailored pharmaceutical approaches, supports precision dosing and informed decision-making. Conclusions: Through clinical examples and pharmacokinetic considerations, we demonstrated that TDM is a cornerstone of personalized medicine, improving outcomes, and reducing adverse effects in anti-infective treatment. Full article

Background: Three-dimensional (3D) printing has been established in pharmaceutical sciences for preparing customized dosage forms with intricate release profiles. However, realizing this potential requires complex design strategies and the careful use of various excipients. This study was designed to evaluate the utility of hypromellose acetate succinate (HPMC-AS) as a singular release-modifying excipient for manufacturing oral solid dosage forms via fused deposition modeling (FDM) 3D printing. Methods: The scope of work encompassed comprehensive material characterization, formulation and production of drug-loaded filaments using hot-melt extrusion (HME), subsequent FDM 3D printing of tablet geometries, and in vitro dissolution studies using mebeverine hydrochloride (MebH) as the model drug. Results: Initial HME processing indicated that the HPMC-AS-based filaments were brittle, presenting technical challenges for direct 3D printing. This issue was successfully overcome by incorporating an additional preheating stage into the FDM printing process, which enabled production of the tablets. Dissolution analysis demonstrated that the 3D-printed mebeverine hydrochloride tablets exhibited delayed and sustained-release characteristics. Conclusions: These results confirm the viability of HPMC-AS as a standalone functional excipient in FDM 3D printing to produce tailored, complex drug delivery systems. Full article

Background/Objectives: Enhancing excipient functionality through environmentally friendly and scalable processing methods is essential for improving the manufacturability and performance of orally disintegrating tablets (ODTs). Microwave-assisted wet granulation enables controlled microstructural modification without chemical alteration of excipient components. This study aimed to develop and evaluate a rice starch (RS)–mannitol co-processed excipient using microwave-assisted wet granulation for direct compression of ODTs. Methods: RS and mannitol were co-processed by wet granulation followed by microwave treatment under varying power levels and irradiation times. The effects of processing conditions on granule morphology, solid-state properties, porosity, powder flow, compressibility, wettability, and disintegration behavior were systematically investigated. The optimized excipient was further evaluated in ODT formulations containing chlorpheniramine maleate and piroxicam and benchmarked against a commercial co-processed excipient (Starlac^®). Results: Microwave treatment generated internal vapor pressure that promoted pore formation and particle agglomeration, resulting in enhanced powder flowability (compressibility index 8.4–10.8%). Partial crystallinity reduction and microstructural modification improved compressibility and surface wettability compared with non-microwave-treated materials. The optimized formulation (MW-RM-H-30) exhibited rapid wetting (25 s), high water absorption (90.5%), low contact angle (42°), and fast tablet disintegration (31 s). ODTs prepared with MW-RM-H-30 showed rapid disintegration (42 s for chlorpheniramine maleate and 32 s for piroxicam) and dissolution behavior comparable to Starlac^®. Conclusions: Microwave-assisted wet granulation provides an efficient, scalable, and environmentally friendly strategy for engineering starch-based co-processed excipients with enhanced functionality for direct compression ODT applications. The developed excipient demonstrates strong potential for solid dosage form manufacturing. Full article

Powder flow is a constant concern in the production of solid dosage forms. Its concise and reliable determination and improvement are challenges for the pharmaceutical industry. Lactose (Lac) and microcrystalline cellulose (MCC) are both widely used pharmaceutical fillers either alone or mixed. In this study, flow determination was performed through methods described on the European Pharmacopoeia. The results obtained showed poor flow and cohesive behavior for Lac and MCC powders and their mixtures (co-processed excipients). The 50% Lac_MCC mixture, with colloidal silicon dioxide (CSD) as the glidant in different proportions, showed relevant improvements in flow. In addition, the effective angle of wall friction (φx), the effective angle of internal friction (φe), arching, and ratholing were also determined, demonstrating the flow behavior in the discharge equipment. Outlet diameters that prevent blockages or insufficient powder flow were also determined. With this study, it was concluded that it was possible to prepare a co-processed excipient with optimal flow behavior composed of Lac_MCC and CSD as a glidant. Full article

Growing demand for rare earth elements (REEs) necessitates the development of efficient recycling strategies from secondary sources. This work presents a complete hydrometallurgical process for recovering yttrium (Y) from spent fluorescent lamps, emphasizing the efficient coupling of a conventional acid leaching with a solid–liquid extraction system. Multi-stage sulfuric acid leaching (2 M, 65 °C, an S/L ratio of 0.25 g/L) achieved a cumulative yttrium dissolution of 71.11% over four stages, with individual stage recoveries (based on initial yttrium content) of 44.2%, 21.56%, 7.19%, and 0.68%. Kinetic and spectroscopic analyses (FTIR, SEM-EDS) revealed that the leaching rate is controlled by diffusion through an in situ formed sulfate-rich layer (CaSO₄, Na₂SO₄), as described by the Z-L-T (Zhuravlev–Leshokin–Templeman) model (Ea = 35.5 kJ mol⁻¹). The resulting leachate was subjected to solid–liquid extraction using Amberlite XAD-7 resin impregnated with D₂EHPA. Under optimal conditions, the extraction process was highly efficient, yielding over 99% yttrium recovery at an optimal pH of 0.75 with a low resin dosage of 0.1 g/L. Furthermore, the solvent-impregnated resins exhibited excellent reusability over five consecutive extraction–stripping cycles, maintaining a single-cycle stripping efficiency above 70% and a cumulative recovery exceeding 97%. This study validates the technical feasibility of an integrated leach–extract–strip process based on impregnated resins as an alternative approach for yttrium recycling from electronic waste, potentially supporting the development of a circular economy. Full article

Background/Objectives: Laser has a prominent place in pharmaceutical industry, especially in the marking of solid dosage forms (SDFs). To combat falsified medicines, this study evaluates QR code marking on the surface of tablets as a supplement to serialization on packaging, using an ultrafast laser to achieve industrially relevant marking speeds while preserving the functional integrity of double film-coated ibuprofen tablets. Methods: Tablets were directly compressed and coated with a double film: the inner layer was a gastro-resistant coating (Acryl-EZE^® MP), while the outer one was a coloured, TiO₂-containing (TC) or TiO₂-free (TF) immediate-release coating (Opadry^®). QR codes were ablated on the tablet surface using various laser parameters (e.g., pulse energy and scanning speed), and the effects were physically, chemically, and microscopically examined to evaluate their properties after this processing. Results: No significant differences were observed between TC and TF coatings. In addition, the readability of QR code is strongly influenced by laser settings and coating types. Furthermore, the used laser has achieved the expected fast marking speed and high-precision coding, which may be economically feasible for pharmaceutical companies. According to the profilometry findings, the ablation depth could be compensated for with an appropriate coating thickness to enable the desired release properties. This was confirmed by the results of SEM, Raman analysis, and in vitro dissolution test. Conclusions: Ultrafast Ti:Sa laser-based QR code marking directly onto the dosage form offers increasing benefits in the healthcare field. However, it may undesirably affect the behavior of the dosage form. This requires careful consideration of formulation and laser processing conditions before application, especially in the case of delayed-release (DR) systems. Full article

Intensive calcination, selection and metallurgical joint comprehensive utilization of solid waste blast furnace gas ash generated by a Chinese iron and steel plant. The main valuable elements in the gas ash are Fe, Pb, Zn, and C, with contents of 22.46%, 3.22%, 10.57%, and 27.02%, respectively. The iron minerals are mainly magnetite and hematite/limonite. Lead exists primarily in the form of lead vanadate and basic lead chloride. Zinc is associated with oxygen, sulfur, and iron in the form of zinc ferrite crystals. The effects of calcination temperature, calcination time, and reducing agent dosage on gasification and reduction indices were investigated. Results showed that using a gasification and reduction calcination–magnetic separation process with weak magnetism, at a calcination temperature of 1150 °C, with 20% anthracite as the reducing agent and a calcination time of 2 h, the volatilization rates of lead and zinc reached 96.70% and 98.26%, respectively. When the roasted ore was ground to a particle size of D₉₀ = 0.085 mm, high-quality iron concentrate with 65.61% iron grade and low lead and zinc contents of 0.08% and 0.17% was obtained, meeting the quality requirements for iron concentrate. The tailings from iron selection can be used as additives in cement and other construction materials. This integrated process combining pyrometallurgy and mineral processing enables the efficient and comprehensive utilization of blast furnace gas dust. Full article

Background: Pediatric patients often receive medicines manipulated from adult formulations due to a lack of age-appropriate products. While such practices are clinically routine, they may reflect deeper systemic deficiencies in pediatric pharmacotherapy. Objective: This scoping review aimed to map the prevalence, definitions, and types of pediatric drug manipulation and to conceptualize manipulation as an indicator of structural gaps in formulation science, regulation, and access. Methods: A systematic search of PubMed (January 2014–July 2024) included 10 studies reporting the frequency of drug manipulation in children aged ≤18 years. Eligible studies were synthesized narratively according to PRISMA-ScR guidelines. Results: Ten studies from nine countries were included, reporting manipulation frequencies ranging from 6.4% to 62% of all drug administrations and up to 60% at the patient level. Manipulated formulations most commonly included oral solid doses, altered through dispersing, splitting, or crushing. Definitions and methodologies varied considerably. The findings revealed five recurring structural gaps: limited pediatric formulations, inconsistent regulatory implementation, lack of standardized definitions and guidance, insufficient evidence on manipulation safety, and inequitable access across regions. Conclusion: Manipulation of finished dosage forms for use in children is a widespread, measurable phenomenon reflecting systemic inadequacies in formulation development, regulation, and access. Recognizing manipulation as a structural indicator may guide policy, innovation, and equitable pediatric pharmacotherapy worldwide. Full article

Glioblastoma (GBM) represents a highly invasive primary malignant tumor within the central nervous system (CNS). Temozolomide (TMZ), a first-line chemotherapy agent for GBM treatment, has significant limitations, including drug resistance, poor water solubility, a short half-life, and notable toxic side effects. The innovation of the TMZ dosage form is pivotal for enhancing its therapeutic efficacy. In this study, solid lipid nanoparticles (SLN) loaded with Angiopep-2 (A2) and TMZ (TMZ-A2SLN), a nanopolymer featuring a solid spherical morphology and a particle size of approximately 100 nm, were constructed. The combined effect of TMZ-A2SLN and small-interfering RNA (siRNA) that can knock down the expression of the HOXB9 gene (siHOXB9) augmented the sensitivity of the glioma cell line U251 to TMZ. Under the combined effect, the viability of U251 cells was reduced by 77%. Meanwhile, the mortality rate increased by approximately 45%, and the cell apoptosis rate rose by around 36%. The number of cells arrested in the G2/M and S phases rose. Proteomic analysis indicates that TMZ-A2SLN might be implicated in the pro-inflammatory signaling cascade, tumor migration, invasion, and angiogenesis during the treatment of glioma cells. Moreover, HOXB9 may play a crucial regulatory role in the PPAR signaling pathway, the neural signaling pathway, the phospholipase D signaling pathway, the IL-17 signaling pathway, mineral absorption, and other pathways during glioma cell treatment. Full article